You're signed outSign in or to get full access.
M28 Capital Management LP
M28 Capital Management LP is an investment advisory firm founded in October 2019 and based in Stamford, Connecticut. Primarily owned by Marc Schneidman, the firm manages investment portfolios and serves institutional investors. As a boutique investment manager, it maintains a small team of investment professionals and is registered with the SEC.
Investment Strategy
M28 Capital Management LP primarily manages equity portfolios with a strong focus on the healthcare and biotechnology sectors, as evidenced by their top holdings in therapeutics and life sciences companies. The firm employs fundamental research to identify undervalued growth opportunities, seeking to generate alpha through rigorous security selection and portfolio construction. Their filings suggest a patient, long-term approach to concentrated investing in innovative healthcare businesses.
Latest 13F Filing Activity
M28 Capital Management LP filed their most recent 13F report on Jun 30, 2025 disclosing 9 equity positions with a total 13F market value of $59M. The fund increased holdings in Invivyd Inc., Fractyl Health Inc., Proqr Thrapeutics N V among other positions. M28 Capital Management LP reduced exposure to Wave Life Sciences LTD, Bridgebio Pharma Inc., Springworks Therapeutics Inc. among others.
Top Holdings
Equity Positions (9)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
W WVE | WAVE LIFE SCIENCES LTD | 62.80% | $36.8M | 5,664,548 | $6.54 | $6.50 | -$8.9M |
I IVVD | INVIVYD INC | 11.28% | $6.6M | 9,248,250 | $5.77 | $0.71 | +$1.0M |
T TGTX | TG THERAPEUTICS INC | 9.92% | $5.8M | 161,600 | $12.60 | $35.99 | -$555.9K |
G GUTS | FRACTYL HEALTH INC | 5.13% | $3.0M | 1,856,117 | $7.45 | $1.62 | +$798.1K |
P PRQR | PROQR THRAPEUTICS N V | 3.55% | $2.1M | 1,019,498 | $2.23 | $2.04 | +$723.8K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more